By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NGM Biopharmaceuticals, Inc. 

630 Gateway Boulevard

South San Francisco  California  94080-7014  U.S.A
Phone: 650-243-5555 Fax: 650-583-1646


Company News
How Merck & Co. (MRK)'s R&D Chief Saved NGM Deal With a Juicy Pitch 2/24/2015 6:23:05 AM
Merck & Co. (MRK) Bets $450 Million on Bay Area's NGM 2/23/2015 5:59:08 AM
NGM Biopharmaceuticals, Inc. Locks Down $50 Million Series C 7/18/2013 8:06:39 AM
AstraZeneca PLC (AZN) and NGM Biopharmaceuticals, Inc. Form Diabetes/Obesity Partnership 6/17/2013 7:09:16 AM
NGM Biopharmaceuticals, Inc., Led by Genentech (RHHBY) Vets Levinson and Goeddel, Raises $13.5 Million 5/6/2013 9:33:29 AM
NGM Biopharmaceuticals, Inc., Janssen Pharmaceutical K.K. Form Alliance for Undisclosed Amount 1/3/2013 8:05:32 AM
NGM Biopharmaceuticals, Inc. and Daiichi Sankyo, Inc. (D4S.F) Collaborate to Discover and Develop Innovative Therapeutics for Diabetes 3/29/2012 10:14:20 AM
NGM Biopharmaceuticals, Inc. Names William J. Rieflin Chief Executive Officer and Director 10/5/2010 6:24:02 AM
NGM Biopharmaceuticals, Inc. Raises $51 Million in Series B Financing and Appoints New Board Member 3/15/2010 7:29:29 AM
NGM Biopharmaceuticals, Inc. Appoints Dr. Arthur D. Levinson, Former Genentech (South SF) (DNA) CEO, to its Board of Directors 10/21/2009 9:02:05 AM